Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

85.99 -1.51 (-1.73%)
Official Closing Price Updated: 7:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,230,697
Open 87.93
Bid (Size) 85.00 (2)
Ask (Size) 85.50 (4)
Prev. Close 87.50
Today's Range 85.92 - 88.24
52wk Range 73.31 - 111.58
Shares Outstanding 2,531,374,696
Dividend Yield 3.77%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inflation's Shadow Lengthens: September CPI Ignites Fed Caution Amidst Government Shutdown
Washington D.C., October 10, 2025 – The financial markets are bracing for impact as the September 2025 Consumer Price Index (CPI) report looms, a critical piece of economic data that promises to shine... 
Via MarketMinute
Topics Bonds Economy World Trade
UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments
UK ministers consider raising NHS drug spending by up to 25% amid pharma investment delays and pressure from US pricing policies. 
Via Benzinga

Performance

YTD
-13.3%
-13.3%
1 Month
+1.0%
+1.0%
3 Month
+2.8%
+2.8%
6 Month
+8.6%
+8.6%
1 Year
-21.6%
-21.6%

More News

Read More
Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation
Via MarketMinute
Topics Artificial Intelligence Economy Government
Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector
Via MarketMinute
Topics Economy
Zoetis (NYSE:ZTS) Declares $0.50 Q4 2025 Dividend, Signaling Robust Animal Health Market
Via MarketMinute
Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
Via MarketMinute
Topics Economy Intellectual Property Retirement
Behind the Scenes of Merck & Co's Latest Options Trends
Via Benzinga
5 Healthcare Plays Powering the Sector’s Big Comeback
Via MarketBeat
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
From Merck & Co., Inc.
Via Business Wire
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
From Merck Sharp & Dohme
Via Business Wire
MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine
Via Benzinga
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment
Via Investor's Business Daily
Merck Completes Acquisition of Verona Pharma
From Merck & Co., Inc.
Via Business Wire
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
From Merck Sharp & Dohme
Via Business Wire
1 Monster Stock in the Making to Buy and Hold
Via The Motley Fool
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets
Via Benzinga
Topics Artificial Intelligence Stocks
Merck & Co's Options: A Look at What the Big Money is Thinking
Via Benzinga
U.S. Jobs Report Stalled Amidst Federal Shutdown: A Critical Information Vacuum for Markets and Policymakers
Via MarketMinute
Topics Bonds Economy
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Via Benzinga
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Via The Motley Fool
Topics Stocks
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
Via TokenRing AI
Topics Artificial Intelligence
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Via MarketMinute
Wall Street Holds Firm Despite Shutdown and Weak Jobs Data
Via Chartmill
Topics Economy
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years
Via Benzinga
Topics Government

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 85.99
When was Merck & Co last traded?
The last trade of Merck & Co was at 10/10/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 217.67B
How many shares of Merck & Co are outstanding?
Merck & Co has 218B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.